Company Cash Funds: Tempus (TEM)

Brandmark of Tempus Labs (TEM)

The aggressive hiring of bioinformaticians and AI specialists contrasts with the focus of Tempus AI, Inc (TEM) on the protected US market, where data regulation minimizes geopolitical risks. The volume of cash reserves demonstrates current liquidity, while 0.61 reflects the latest value of the metric. Business stability relies on access to biomedical datasets, government grants, and the development of personalized medicine.

TEM - Tempus AI, Inc. Company Cash and Cash Equivalents over the range 06/15/2024 - 11/21/2026

Analytical breakdowns for Tempus AI, Inc

- stock quotes and analyst forecast:
- company stock exchange capitalization indicators:
Summary company analysis:tempus.com
Brand item of Tempus

Tempus AI, Inc (TEM) leads the precision medicine sector by leveraging the world's largest database of clinical-molecular data. This cash position chart allows for an assessment of the high-liquid resources required to shield the business from market risks. This metric measures the free cash balance, revealing capital management efficiency and the risk of excessive capital freezing. A stable liquidity level confirms the company's financial resilience amidst fierce competition with big-tech behemoths.

Competitors of Tempus AI, Inc (TEM)

Company Cash Volume QGEN|IONS - Company Cash Reserve|Company Cash Funds Repligen RGEN|RNA: Company Cash and Cash Equivalents|CRSP: Company Cash on Hand|GeneDx Corp (WGS) - Company Cash on Hand|RARE: Company Cash Volume|BEAM - Company Liquid Assets|SRPT (Sarepta Therapeutics) - Company Cash Volume|Company Cash on Hand Twist Bioscience Inc (TWST)|Company Cash Volume TXG|Company Liquid Assets Intellia|Stoke - Company Cash on Hand|BLFS: Company Cash and Cash Equivalents|Wave Life Sciences Corp - Company Cash Volume|Maze Therapeutics, Inc. (MAZE) - Company Cash on Hand|Sionna Therapeutics Inc (SION) - Company Cash Funds|Company Cash on Hand Prime Medicine Corp|Company Cash Funds tayshagtx.com|QURE - Company Cash Position|Company Cash on Hand MGTX (MeiraGTx Holdings plc)|REGENXBIO (RGNX) - Company Cash Position|Company Cash Volume SLDB (Solid Biosciences Inc.)|Company Cash Balance OCGN|PacBio Corp - Company Cash Volume|Benitec Biopharma Inc. (BNTC) - Company Cash on Hand|DSGN: Company Cash Volume|Company Cash and Cash Equivalents RCKT|Company Cash on Hand FDMT|Company Cash and Cash Equivalents LXEO (Lexeo Therapeutics)|Company Cash Volume KRRO|Editas Medicine, Inc. - Company Cash and Cash Equivalents|Company Cash Funds Silence Therapeutics Inc. SLN|Company Cash Volume ProQR Therapeutics N.V. PRQR|CDXS: Company Cash on Hand|Company Cash Position Sangamo (SGMO)|NAUT (Nautilus Bio) - Company Cash on Hand|MGX - Company Liquid Assets|DTIL (Precision BioSciences Inc.) - Company Cash Volume|generationbio.com (GBIO) - Company Liquid Assets|Company Cash Funds Boundless Bio Inc (BOLD)|Company Cash Volume Exicure Inc. (XCUR)|Company Cash Funds imunon.com IMNN|Company Cash Volume Phio Pharmaceuticals PHIO|Mustang Bio Inc - Company Cash Volume|Company Cash Reserve transcodetherapeutics.com|BNGO: Company Cash Volume|Company Cash and Cash Equivalents APDN|BLUE (bluebirdbio.com) - Company Cash Volume|Company Cash Reserve ImmunoPrecise Antibodies IPA|Company Cash on Hand OMGA (omegatherapeutics.com)|Company Cash Volume Singular Genomics Systems, Inc. (OMIC)|Company Cash Volume RGLS (Regulus Therapeutics, Inc.)|Company Cash Volume Syros SYRS|Telesis Bio, Inc. - Company Cash Volume|TRACON Pharmaceuticals (TCON) - Company Cash on Hand|UBX: Company Cash Volume